Cargando…
Poster 1002: Galectin-3 as predictive biomarker of airways remodeling modulation in omalizumab treated severe asthma patients
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
World Allergy Organization
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4082049/ http://dx.doi.org/10.1186/1939-4551-7-S1-P3 |
_version_ | 1782324194918268928 |
---|---|
author | Mauri, Pierluigi Riccio, Annamaria Rossi, Rossana Di Silvestri, Dario Benazzi, Louise De Ferrari, Laura Dal Negro, Roberto W Canonica, G Walter |
author_facet | Mauri, Pierluigi Riccio, Annamaria Rossi, Rossana Di Silvestri, Dario Benazzi, Louise De Ferrari, Laura Dal Negro, Roberto W Canonica, G Walter |
author_sort | Mauri, Pierluigi |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-4082049 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | World Allergy Organization |
record_format | MEDLINE/PubMed |
spelling | pubmed-40820492014-09-11 Poster 1002: Galectin-3 as predictive biomarker of airways remodeling modulation in omalizumab treated severe asthma patients Mauri, Pierluigi Riccio, Annamaria Rossi, Rossana Di Silvestri, Dario Benazzi, Louise De Ferrari, Laura Dal Negro, Roberto W Canonica, G Walter World Allergy Organ J Poster Presentation World Allergy Organization 2014-02-03 /pmc/articles/PMC4082049/ http://dx.doi.org/10.1186/1939-4551-7-S1-P3 Text en Copyright © 2014 Mauri et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Poster Presentation Mauri, Pierluigi Riccio, Annamaria Rossi, Rossana Di Silvestri, Dario Benazzi, Louise De Ferrari, Laura Dal Negro, Roberto W Canonica, G Walter Poster 1002: Galectin-3 as predictive biomarker of airways remodeling modulation in omalizumab treated severe asthma patients |
title | Poster 1002: Galectin-3 as predictive biomarker of airways remodeling modulation in omalizumab treated severe asthma patients |
title_full | Poster 1002: Galectin-3 as predictive biomarker of airways remodeling modulation in omalizumab treated severe asthma patients |
title_fullStr | Poster 1002: Galectin-3 as predictive biomarker of airways remodeling modulation in omalizumab treated severe asthma patients |
title_full_unstemmed | Poster 1002: Galectin-3 as predictive biomarker of airways remodeling modulation in omalizumab treated severe asthma patients |
title_short | Poster 1002: Galectin-3 as predictive biomarker of airways remodeling modulation in omalizumab treated severe asthma patients |
title_sort | poster 1002: galectin-3 as predictive biomarker of airways remodeling modulation in omalizumab treated severe asthma patients |
topic | Poster Presentation |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4082049/ http://dx.doi.org/10.1186/1939-4551-7-S1-P3 |
work_keys_str_mv | AT mauripierluigi poster1002galectin3aspredictivebiomarkerofairwaysremodelingmodulationinomalizumabtreatedsevereasthmapatients AT riccioannamaria poster1002galectin3aspredictivebiomarkerofairwaysremodelingmodulationinomalizumabtreatedsevereasthmapatients AT rossirossana poster1002galectin3aspredictivebiomarkerofairwaysremodelingmodulationinomalizumabtreatedsevereasthmapatients AT disilvestridario poster1002galectin3aspredictivebiomarkerofairwaysremodelingmodulationinomalizumabtreatedsevereasthmapatients AT benazzilouise poster1002galectin3aspredictivebiomarkerofairwaysremodelingmodulationinomalizumabtreatedsevereasthmapatients AT deferrarilaura poster1002galectin3aspredictivebiomarkerofairwaysremodelingmodulationinomalizumabtreatedsevereasthmapatients AT dalnegrorobertow poster1002galectin3aspredictivebiomarkerofairwaysremodelingmodulationinomalizumabtreatedsevereasthmapatients AT canonicagwalter poster1002galectin3aspredictivebiomarkerofairwaysremodelingmodulationinomalizumabtreatedsevereasthmapatients |